Company

News

The common goal is the advancement of women’s health and welfare, through tackling the most burdensome crisis facing the female population, such as cervical cancer.

European Journal of Obstetrics & Gynecology and Reproductive Biology

Author
ntlnoida
Date
2021-03-15 00:22
Views
105


European Journal of Obstetrics.pptx

Among 4,117 women who simultaneously or subsequently underwent Pap cytology, HPV test, cervicography, colposcopically directed biopsy, cervicography and Pap co-testing had superior screening capacity (sensitivity: 97.5% vs 93.7%) and cost-effectiveness (cost: $1,474 vs $1,135) for detection of pre-invasive cervical lesions than HPV and Pap co-testing and may be an effective and cost saving screening strategy in clinical practice in country with a high prevalence of cervical cancer.